Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEP005 gel for Actinic Keratosis on the head
NCT00916006Phase 3Completed
- Sponsor
- Peplin
- Start
- Jun 2009
- Primary completion
- Sep 2009
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ingenol mebutate in actinic keratosis (AK), sponsored by Peplin. Started Jun 2009; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00916006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916006.